The study found the combination to significantly improve negative schizophrenia symptoms, and people taking both drugs experienced fewer of the adverse effects commonly associated with haloperidol, an earlier, smaller, open-label trial had found
ondansetron to be useful in treating antipsychotic-induced
tardive dyskinesia in people with schizophrenia, and the study patients also showed significant improvement in the disease's symptoms.